Product Information
ENTECAVIR 1 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3684 per EA under NDC 65862084230. Its NADAC has been published 573 times since Oct 14, 2015.
FDA first approved this application on Aug 26, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862084230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206217FDA Approved
8/26/2015
TE Code
AB
On Market Since
8/26/2015
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 1 MG TABLET has been published 573 times since Oct 14, 2015, and over the history we have for it it has declined 98.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3684 per EA |
|---|---|
| All-time high | $29.5825 (Oct 14, 2015) |
| All-time low | $0.3119 (Feb 18, 2026) |
| 52-week high | $0.4888 |
| 52-week low | $0.3119 |
| Median price | $1.3028 |
| Average price | $3.9013 |
| Largest weekly change | +93.7% (Jan 19, 2022) |
| Weeks tracked | 573 |
| Tracking since | Oct 14, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Entecavir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENTECAVIR 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 1 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.3684 per EA (NDC 65862084230), effective Sep 30, 2026.
How has the price of ENTECAVIR 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 1 MG TABLET has declined 98.8%. It has been tracked across 573 weekly CMS publications since Oct 14, 2015.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 1 MG TABLET?
Since Oct 14, 2015, the NADAC for ENTECAVIR 1 MG TABLET has ranged from a low of $0.3119 (Feb 18, 2026) to a high of $29.5825 (Oct 14, 2015), with a median of $1.3028 per EA.
Are there cheaper alternatives to ENTECAVIR 1 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ENTECAVIR 1 MG TABLET?
ENTECAVIR 1 MG TABLET (NDC 65862084230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.